fourth annual section goes here symposium...nupf annual symposium 2016 | 3 david giljohann from the...

NUPF ANNUAL SYMPOSIUM 2016 | 1

SECTION GOES HERE

A JOURNEY

THROUGH SCIENCE:

EXPLORING DIVERSE

CAREER PATHWAYS

Postdoctoral ForumNorthwestern University

NUPF

FOURTH ANNUAL SYMPOSIUM (2016)

2 | NUPF ANNUAL SYMPOSIUM 2016

12:00pm-12:45pm Registration, Poster Setup Ryan Family Atrium, Robert H. Lurie Building, 303 E Superior St

12:45pm-1:30pm Official Welcome, Keynote Address David Giljohann, CEO of Exicure, Inc.

McGaw Auditorium, 2nd floor, Mary & Foster McGaw Pavilion, 710 N Faribanks Ct

1:30pm-1:45pm Coffee break Ryan Family Atrium, Robert H. Lurie Building, 303 E Superior St

1:45pm-3:15pm Postdoctoral/Graduate Student Poster Session Ryan Family Atrium, Robert H. Lurie Building, 303 E Superior St

- Even poster numbers present 1:45-2:30 pm - Odd poster numbers present 2:30-3:15 pm

3:30pm-4:35pm Postdoctoral Speakers McGaw Auditorium, 2nd floor, Mary & Foster McGaw Pavilion, 710 N Faribanks Ct

4:35pm-4:45pm Office for Research Safety Address Michael B. Blayney, PhD, Executive Director, Research Safety McGaw Auditorium, 2nd floor, Mary & Foster McGaw Pavilion, 710 N Faribanks Ct

4:45pm-5:00pm Closing Remarks and Award Presentation Alicia Löffler, PhD, Associate Provost for Innovation & New Ventures, Associate Vice President for Research, Executive Director of INVO (Innovation and New Ventures Office)

McGaw Auditorium, 2nd floor, Mary & Foster McGaw Pavilion, 710 N Faribanks Ct

5:00pm-6:00pm Networking Reception Ryan Family Atrium, Robert H. Lurie Building, 303 E Superior St

1:30pm-5:00pm Professional Headshots (pre-registered) 2-322, Mary & Foster McGaw Pavilion, 710 N Faribanks Ct

Event Program


David GiljohannFrom the Bench to the Clinic- Spherical Nucleic Acids and the Story of Starting Exicure

David Giljohann is the CEO of Exicure, Inc., a clinical stage biotechnology company developing a new class of immunomodulatory and gene silencing drugs. Dr. Giljohann completed his Ph.D. in the laboratory of Dr. Chad A. Mirkin at Northwestern University where he developed oligonucleotide-modified nanoparticles, including NanoFlare™, and spherical nucleic acid constructs. Dr. Giljohann has been recognized for his work with a Materials Research Society Gold Award, Baxter Innovation Award, Rappaport Award for Research Excellence, NSEC Outstanding Research Award, and as a finalist in the National Inventors Hall of Fame Collegiate Inventors Competition.

DIRECTIONS TO McGAW AUDITORIUM (McGAW PAVILION) FROM RYAN FAMILY ATRIUM (LURIE BUILDING):

Exit Lurie at Huron St, cross Fairbanks Ct and continue down Huron to the McGaw entrance. Take the elevator to Level 2. Turn Right.

McGAW (& OLSON) PAVILION ROBERT H. LURIE BUILDING

N F

airb

anks

Ct

POST

ER S

ESSI

ON

RECEPTION

Superior St

Huron St

REGISTRATION

RYAN FAMILY ATRIUM

McGAW ADITORIUM (LEVEL 2)

Keynote Address

McGaw Auditorium12:45pm - 1:30pm


Katarina Kotnik Halavaty, PhDDrug Transport and Simian-HIV Infection in the TDF Intravaginal Ring Treated Pigtail Macaque sCell and molecular biology (HIV) Lay SummaryHuman Immunodeficiency Virus (HIV) causes Acquired Immune Deficiency Syndrome. Approximately 37 million people are currently infected with HIV worldwide. There is no cure for HIV and the virus continues to be a significant cause of global mortality with a total of 24 million accumulated AIDS-related deaths to date. Highly Active Antiretroviral Therapy reduces viral load and leads to prolonged survival. Though oral pre-exposure prophylaxis efficiently prevents HIV transmission, the main obstacles of this treatment are common side effects such as nausea, diarrhea, headache, depression etc. To overcome adverse effects caused by systemic distribution of antiviral drugs, a new prevention technology, the intravaginal ring (IVR) was developed to topically deliver an antiretroviral drug and prevent sexual transmission of HIV in the female reproductive tract. In this study we examine a novel medical device, the tenofovir disoproxil fumarate (TDF) IVR in pigtail macaques that were challenged with a single high dose simian-HIV.

Scientific AbstractA novel tenofovir disproxil fumarate intravaginal ring (TDF IVR) was developed to offer protection against HIV infection in women by long lasting drug adherence in genital mucosa. Our previous findings demonstrated viral infection throughout the female reproductive tract (FRT) in non-human primates. In this study we show correlation between sites of infection and drug distribution within an IVR-protected macaque FRT.A single round non-replicative SIV-based vector expressing luciferase and mCherry reporter genes was vaginally administered into six pigtail macaques that were TDF-IVRs treated for 28 days. The isolated FRTs were analyzed for initial sites of infection by observing luciferase activity in luciferin-soaked tissues using an In Vivo Imaging System. The tissue was dissected and further analyzed with fluorescent microscopy and nested PCR to identify additional sites of infection. Drug levels were quantified in tissue samples using Liquid chromatography-tandem mass spectrometry (LC-MS/MS) method.In vivo imaging demonstrated luciferase activity in the ovaries of two animals. Transduced cells expressing luciferase and mCherry genes were found in the ovaries of 5 pigtail macaques. Nested PCR was optimized to detect a single copy of proviral DNA in infected cells. Using this highly sensitive PCR method we demonstrated frequent viral infections in vagina and cervix in four of six IVR-treated animals. TFV concentrations were measured and found to be variable throughout the FRT. The highest drug concentrations were detected in the upper vagina/lower cervical area, near the site of the ring. TFV levels decreased with the distance from the ring location, such as in ovaries and uterus. Our results demonstrate the close relationship between repeated sites of viral infection and gradient of tissue drug concentrations decreasing from the site of the ring.

Yuanzhang Xiao, PhDDesign of Efficient Electricity Markets For Smart GridElectrical Engineering and Computer Science (Power systems, renewable energy)

Lay SummaryWe study the integration of renewable energy (e.g., wind, solar) into electricity markets. Electricity markets are essential to balance the supply and demand in power systems, and hence ensure the stability of the grid. However, with the increasing penetration of renewable energy, it is more challenging for the market to balance the supply and demand due to the unpredictable nature of renewable energy. This uncertainty in renewable energy generation affects both the market participants (e.g., energy producers) and the market operator. In this work, we propose a new equilibrium model that predicts the market outcome more accurately when the participants are faced with the uncertainty of renewables. Our results also shed light on how the market operator can run the market more efficiently

Scientific AbstractWe study a two-stage electricity market with renewables. Each energy producer in the market has a portfolio of both renewable and conventional energy generators. In the day-ahead (DA) market, each producer submits a parameterized supply function (i.e., the amounts of energy to produce at various prices) to the independent system operator (ISO), who determines the DA market clearing price and the amounts of DA committed energy by each producer. In the real-time market, each producer tries to fulfill its DA committed energy with (zero-cost) renewables. If the renewable energy is insufficient, the producer uses conventional energy generation and incurs a cost; otherwise, it sells the surplus of renewable energy to the ISO at a predetermined feed-in tariff.We study the robust supply function equilibrium (SFE) in this market, where each producer has incomplete information about the other producers’ marginal costs and the distribution of its random renewable energy, and performs worst-case optimization against these unknown variables. We fully characterize the unique robust SFE, and study the impact of the feed-in tariff on the equilibrium outcome. In particular, we show that it may be inefficient to set the feed-in tariff too high (i.e., higher than the marginal costs of all the producers’ conventional energy generation).

Postdoctoral Talk Abstracts

McGaw Auditorium3:30pm - 4:30pm


Eduard Sleep, PhDInjectable Biomimetic Scaffolds for Muscle RegenerationSimpson Querrey Institute (Biomaterials)

Lay SummaryWe all have progenitors in our skeletal muscles that are called muscle stem cells (MuSCs). These MuSCs replenish our muscle cell pool during normal wear and tear conditions. However, upon injury or disease, MuSCs can become challenged and not be enough to regenerate the muscle on their own. This is why we are seeking for ways to transplant new or “better” MuSCs into muscles. We have developed an injectable 3-dimensional scaffold that is made of nanometer-sized fibers oriented in the same direction. This scaffold not only allows for muscle progenitor cells to align and fuse with one another like they do in your body, but it also allows them to proliferate. We are using these scaffolds to enhance MuSC transplantation therapies.

Scientific AbstractMuscle stem cells are a potent population dedicated to efficacious skeletal muscle regeneration, but their therapeutic utility is currently limited by mode of delivery. We developed a biomimetic cell delivery technology based on peptide amphiphiles (PAs) that assemble to encapsulate cells and growth factors within a muscle-like unidirectionally-ordered environment of long and aligned nanofibers. The stiffness of the PA scaffolds, dependent on amino acid sequence, was found to determine the macroscopic degree of cell alignment templated by the nanofibers. Furthermore, these PA scaffolds support myogenic progenitor cell survival and proliferation and they can be optimized to induce cell differentiation and maturation. We engineered an in vivo delivery system to assemble scaffolds by injection of a PA solution that enabled co-alignment of scaffold nanofibers with endogenous myofibers. These scaffolds locally retained growth factors, displayed degradation rates matching the time course of muscle tissue regeneration, and markedly enhanced the engraftment of muscle stem cells in injured and non-injured muscles in mice.

Kristen Rosen, PhDIs There an App for That? An Exploratory Randomized Controlled Trial of App-based Mindfulness Training for Women with Breast CancerPreventive Medicine (Health Psychology)

Lay SummaryMindfulness, one’s attention to and awareness of current thoughts, feelings, and behaviors, may help improve quality of life (QOL) among women with breast cancer. However, attending a traditional mindfulness training program may not be possible for some women. This project evaluated whether using a commercial mindfulness app (Headspace®) to deliver mindfulness training may help improve QOL among women with breast cancer, compared to no intervention. Participants were 95 women who were diagnosed with breast cancer within the past 5 years. Overall, 48 participants were randomly assigned to receive the mindfulness app at the beginning of the study and 47 participants were waitlisted to receive the app after they completed the study. QOL and mindfulness was measured at four time points throughout the study (baseline, 5, 9, and 12 weeks). Findings suggest that participants receiving the app had higher QOL by week 9, compared to participants who did not receive the app. Although these findings suggest using an app to deliver mindfulness training to women with breast cancer may be feasible, additional research is needed.

Scientific AbstractBackground: Mindfulness training may support self-management of symptoms and treatment side-effects among women with breast cancer. However, attending instructor-facilitated mindfulness training may be burdensome for some women, and the clinical benefit of many self-directed mindfulness training apps is currently unknown. This project evaluated the efficacy of a commercially available mindfulness training app (Headspace®) among women diagnosed with breast cancer within the past 5 years (n = 95). An exploratory parallel group randomized controlled trial compared app-delivered mindfulness training (AMT) to a waitlist control (WC) over 8 weeks with 4 additional weeks of follow-up. Breast cancer-related quality of life (QOL) was evaluated as the primary outcome.Methods: All data collection was web-based. QOL and mindfulness were assessed at 4 time points: baseline, 5, 9, and 12 weeks. Participant characteristics and perceived health literacy were assessed at baseline. Participants assigned to AMT (n = 48) were asked to use Headspace® for 8 weeks. Dose was defined as completion of ≥ 1 Headspace® training session. Participants assigned to WC (n = 47) received the app after completing follow-up questionnaires. All participants received a free 6-month subscription to Headspace®. Results: Groups were comparable at baseline in terms of characteristics, perceived health literacy, QOL, and mindfulness. An intent to treat analysis was conducted using linear mixed effects models. Findings revealed a time by group interaction such that higher QOL was observed among the AMT group at week 9, compared to those assigned to WC t(310) = 2.52, p = 0.01. However, the degree of change in mindfulness between groups did not appear to be statistically significant from baseline through week 12.Conclusion: Using an app-based approach to deliver mindfulness training to women with breast cancer may be feasible. Findings from this exploratory study may have implications for remote delivery of breast cancer supportive care. However, additional evidence is needed to support the generalizability of these findings.

Postdoctoral Talk Abstracts


NUPF


Agnes Laskowski, PhDTrans-Chromosomal X Silencing Underlying Female Dominant LupusCell and Molecular Biology (Autoimmunity)

Lay SummaryLupus affects over one million Americans and involves the inappropriate activation of the immune system against self-antigens, leading to inflammation and tissue damage. Individuals suffering from lupus have an increased rate of long-term disability and shortened life span with the most damaging side effects occurring from non-specific maintenance therapy. An intriguing feature of lupus is that it is nine times more common in females than males strongly suggesting a genetic predisposition when two X chromosomes are present. In collaboration with neighboring clinicians we have observed a novel phenomenon in human female blood cells in which two X chromosomes co-localize leading to inappropriate gene repression. Our work will determine whether this unique phenomenon underlies the increased incidence of lupus in women as well as aim to disrupt this mechanism for future treatment development. This new strategy of therapy would prevent life-long tissue damage as well as eliminate dependence on cytotoxic therapies.

Scientific AbstractLupus involves the inappropriate activation of the adaptive immune system against self-antigens, leading to inflammation and damage to various tissues of the body. Current treatment involves corticosteroids, general immunosuppression, and anti-inflammatory agents to temporarily alleviate secondary symptoms once the active phase of the disease has been initiated. These drug schedules fail to achieve the ultimate goals of remission and cure. Our central objective is to identify selective and potent small molecule inhibitors that target dysfunctional B and T lymphocytes in women during the active phase of lupus. Lupus is nine times more common in females than males. The preponderance of female lupus patients suggests a genetic predisposition of two X chromosomes contributing to the onset of the disease. This predisposition is further supported by the increased incidence of lupus in males with Klinefelter’s syndrome (47, XXY), in which lupus prevalence is equivalent to normal females (46, XX). In addition, mouse genetic studies have shown that the presence of two X chromosomes specifically exacerbates autoimmune responses.From our analysis of the three-dimensional organization of chromosomes in human female nuclei, we have identified an abnormal frequency of chromosome X co-localization in natural regulatory T cells (nTregs), as compared to other female cell types. nTregs are responsible for attenuation of the adaptive immune response, and the master regulatory transcription factor for the lineage, Foxp3, is encoded on the X chromosome. We find that co-localization of the active X with the inactive X leads to the spreading of repressive epigenetic marks. We hypothesize that this phenomenon, trans-chromosomal X gene repression, leads to lymphocyte dysfunction in women and results in their susceptibility to lupus. Successful completion of this project will identify a novel proactive treatment strategy by inhibiting initiation of the active phase through maintaining expression of genes critical for lymphocyte development and function.

Sameer Patwardhan, PhDIntroducing Perovskite Solar Panels to UndergraduatesArgonne-Northwestern Solar Energy Research Center (Materials Science and Engineering)

Lay AbstractSolar electricity production has witnessed an exponential growth in recent years. To meet workforce demands in future, and for public awareness, an effective strategy would to be to engage students into learning solar energy science, technology and policy. Interestingly, science instructors have limited resources to provide hands-on learning experiences on solar energy. To address this gap, we have designed a unique ‘solar cell kit’ to easily and cheaply build solar panels from chemical ingredients. The activity takes 1-2 hours, requires standard laboratory equipment, and costs less than one dollar. This multidisciplinary experiment exposes students to various concepts in STEM disciplines. The kit, which is based on proprietary work at Northwestern, is becoming popular in schools and universities worldwide. During the presentation, I will build a solar panel from scratch in less than one minute!

Scientific AbstractThe emergence of perovskite solar cells and their facile solution-based fabrication method offer a unique opportunity to give chemistry students hands-on experience in mainstream photovoltaics. In the first-of-its-kind laboratory experiment, we provide an easy and cheap way to fabricate perovskite cells that are connected to create solar panels that can power electronic devices. This multidisciplinary experiment takes only 1-2 hours of time, requires standard laboratory equipment, and costs less than one dollar. This experiment, which is based on proprietary work at Northwestern, has already benefited thousands of students at schools and universities worldwide. During the presentation, I will describe the experiment, the underlying science, and its implementation into general chemistry courses at Northwestern. To put a cherry on top, I will demonstrate solar panel fabrication from starting materials in less than a minute!

Postdoctoral Talk Abstracts (cont’d)


1. A Role for Extra-junctional αE-catenin Homodimersin Cell-Cell Contact Formation Megan Novak (Pulmonary)

2. Molecular Approaches in Quantum Computing Joseph Zadrozny, PhD (Chemistry)

3. Surgically-Friendly “Tissue Papers” from Organ-Specific Decellularized Extracellular Matrices Adam Jakus, PhD (Materials Science and Engineering, Surgery)

4. “Donor”-Specific Regulatory T Cells for Clinical Transplant Tolerance: Optimization of ex vivo Expansion and Characterization Jessica Heinrichs, PhD (Surgery)

5. Immunoregulatory and myelin repair therapies in T cell-mediated mouse models of Multiple Sclerosis Haley Titus, PhD (Microbiology-Immunology)

6. β- and α-secretase processing of Amyloid Precursor Protein in human central nervous system: implications for Alzheimer’s disease. Justyna Dobrowolska Zakaria, PhD (Cell and Molecular Biology)

7. Early cytoplasmic uncoating is necessary for infectivity of HIV-1 João Mamede, PhD (Cell and Molecular Biology)

8. The Legionella pneumophila Major Metalloprotease is Translocated Out of the Pathogen Vacuole in a Novel, Type II Secretion-dependent Manner Hilary Truchan, PhD (Microbiology-Immunology)

9. Serum Phosphate and Retinal Microvascular Changes: The Multi-Ethnic Study of Atherosclerosis (MESA) and the Beaver Dam Eye Study (BDES) Rupal Mehta, PhD (Medicine / Nephrology)

10. Engineered Magnetic Nanostructures (MNS): Role of Composition and Surface Coating on Theranostic Properties Vikas Nandwana, PhD (Materials Science and Engineering)

11. VEGF-based nanotherapy in Spinocerebellar ataxia type 1 (SCA1) Yuan-Shih Hu, PhD (Neurology)

12. CD95/Fas increases stemness in cancer cells by inducing a STAT1 dependent Type I interferon response Abdul Qadir Syed, PhD (Hematology/Oncology)

13. Decoding parts of speech from neural signals Emily Mugler, PhD (Neurology)

14. Nitrogenase-mimic chalcogels for photochemical reduction of dinitrogen to ammonia Jian Liu, PhD (Chemistry)

15. Mucin-binding IgG: Characterizing a novel antibody effector function and discovery of a new Fc Receptor Jeffrey Schneider, PhD (Cell and Molecular Biology)

16. Probing the copper coordination environment in a Cu2+ transporting P1B-ATPase: Spectroscopic and functional studies Rahul Purohit, PhD (Department of Molecular Biosciences)

17. Plasmon-Driven Hot Electron Chemistry in Isotopically Edited 4,4’-Bipyridine Gold Nanoantennas Emily Sprague-Klein (Applied Physics)

18. NKCC1 inhibitor rectifies critical period synaptic development and plasticity in Fragile X mice Qionger He, PhD (Physiology)

19. Liver-Derived Decellularized Extracellular Matrix Gels Induce Complex Branching and Bile Ductule Network Formation of Cholangiocytes In Vitro. Phillip Lewis (Biomedical Engineering)

Poster Presentations

Ryan Family Atrium (Lurie)1:45pm - 3:15pm


20. Bidirectional virulence modulation of Vibrio vulnificus by the MARTX toxin effector domain region Hannah Gavin (Microbiology-Immunology)

21. What Physical Activity Intensity and Duration Matters Most for Anthropometric Outcomes? Amanda Paluch, PhD (Preventive Medicine)

22. Understanding Health Disparities Among Racial Groups in the United States: A Perspective through Access to Care Andrew Wang (IPHAM)

23. Pyridylamido Bi-Hafnium Olefin Polymerization Catalysis: Conformationally Supported Hf···Hf Enchainment Cooperativity Yanshan Gao, PhD (Chemistry)

24. The Transcription Factor Miz1 in Chronic Obstructive Pulmonary Disease (COPD) Cong Chen, PhD (Medicine)

25. Vimentin filament precursors exchange subunits in an ATP-dependent manner. Amelie Robert, PhD (Cell and Molecular Biology)

26. Spatio-Temporal Biomechanical Effects of Abl Kinases on Endothelial Cytoskeleton. Xin Wang, PhD (Materials Science and Engineering)

27. High-density lipoprotein (HDL) functionalized magnetic nanostructures (HDL-MNS): Theranostic agents for cardiovascular disease treatment Soo-Ryoon Ryoo, PhD (Materials Science and Engineering)

28. Peptide-siRNA nanoparticles for neural cell protein knockdown Armando Hernandez-Garcia, PhD (Simpson Querrey Institute for Bionanotechnology)

29. Divergent Wnt Signaling Regulates Glioma Stem Cells and Tumor Phenotype. Angel Alvarez, PhD (Neurology)

30. Uncovering cell type-specific events in a C. elegans model of Huntington’s disease Laura Bott, PhD (Molecular Biosciences)

31. Extracting Informative C. elegans Phenotypes with Machine-Learning Peter Winter, PhD (ChBE)

32. Toward Design Rules for Enzyme Immobilization in Hierarchical Mesoporous Metal-Organic Frameworks Peng Li, PhD (Chemistry)

33. A Novel Regulator of Hepatic Metabolism and Glucose Homeostasis. Meredith Sommars (Medicine)

34. The role of the orbitofrontal cortex in the continued pursuit of unsatisfied goals James Howard, PhD (Neurology)

35. Genomic Control of Healthful Obesity Madhavi Senagolage (Endocrinology)

36. Genomic regulation of skeletal muscle metabolism Krithika Ramachandran (Endocrinology)

37. NullSeq: A Tool for Generating Random Coding Sequences with Desired Amino Acid and GC Contents. Sophia Liu (Chemical and Biological Engineering)

38. Large-Scale Identification of New Secondary Metabolites Using Heterologous Expression and Metabolomic Screening of Fungal Biosynthetic Gene Clusters Kenneth Clevenger, PhD (Chemistry of Life Processes Institute)

39. Plasmon-Mediated Electron Transport in a Molecular Junction Partha Pal, PhD (Chemistry)

Poster Presentations (cont’d)


40. Six3 regulation of FoxG1 expression in the anterior neuroectoderm Sandra Acosta Verdugo, PhD (FCVRI)

41. The Pathophysiological Role of MYBPHL in Dilated Cardiomyopathy David Barefield, PhD (Center for Genetic Medicine)

42. Establishing an integrated ex-vivo female reproductive tract in the microfluidic platform: screening of reproductive toxic chemicals Shuo Xiao, PhD (Obstetrics and Gynecology)

43. Cross talk between Vibrio cholerae MARTX toxin effector domains modulate the chemokine IL-8 Patrick Woida (Microbiology-Immunology)

44. Imaging the Development of Aqueous Corrosion Xiaoxiang Yu, PhD (Materials Science and Engineering)

45. Salvatore Nocadello, PhD (Biochemistry)

46. Andrew Stephens, PhD (Molecular Biosciences)

47. Liang Liu, PhD (IEMS)

48. Ashlee Howarth, PhD (Chemistry)

49. Trans-Chromosomal X Silencing Underlying Female Dominant Lupus Agnes Laskowski, PhD (Cell and Molecular Biology)

Poster Presentations (cont’d)


NUPF

Find out more at www.nupf.org/about-us


NUPF gratefully acknowledges support from our sponsors at NU:

Office of Postdoctoral Affairs Office for Research

The Graduate SchoolWeinberg College of Arts & Sciences

Feinberg School of MedicineMcCormick School of Engineering and Applied Science

International Office

Special thanks to the Office for Research Safety for sponsoring the awards:

2016 NUPF Symposium Organizing Committee:

Veronika Hoeke, PhD, NUPF ChairMarco Biancucci, PhD, Career & Professional Development Committee (CAP) Chair

Dean Procter, PhD, Web Coordinator & CAP MemberMichelle Harris, PhD, Social Committee Chair

Haley Titus, PhD, TreasurerThomas Stoeger, PhD, CAP Member

Serena Tommasini Ghelfi, PhD, CAP MemberLuca Lonini, PhD, CAP Member

Ana Vicente-Sanchez, PhD, CAP Member


NUPF

Monthly Coffee Hour Next (with OPA): 9-11am September 20 (Evanston) September 21 (Chicago)

Monthly Happy HourNext: 6pm September 28 at 52Eighty Rooftop Lounge

(Walk from Chicago Campus)

www.nupf.orgJoin other Northwestern postdocs for regular social events,

career and professional development events or special international comittee events

Find out more about our upcoming events at: www.nupf.org/events

facebook.com/nupostdocforuminstagram.com/nupostdoc twitter.com/nupostdoc

Oct 13: Inter-cultural competence 101Oct 20: Personal leadership skills

Oct 27: Negotiating conflicts

fourth annual section goes here symposium...nupf annual symposium 2016 | 3 david giljohann from the...

Documents